Join the first of the Our Future Is Science 2022 Community Talk Series, on intersections between health and social justice. This series is part of the Mentorship and Leadership programs of Our Future Is Science and is open to members of the public as well.
Three distinguished panelists will discuss intersections between health and social justice, including root causes of health disparities and inequities, participation in clinical trials, and using science to key societal challenges.
Brittney N. Doyle, MPH, WISE Health San Francisco, Founder and Managing Director
Brittney N. Doyle is the Founder and Managing Director of WISE Health San Francisco, a public health consulting company that specializes in developing community engagement strategies designed to address barriers associated with the health inequities found in under-served communities. Her efforts focus on advancing strategies related to increasing free health services, preventing HIV and addressing health behaviors such as social isolation and care coordination on local levels. Ms. Doyle collaborates with community organizations, government agencies, health clinics and academic institutions to ensure that these populations are reached where they work, live, play, and pray. She is passionate about developing innovative, interactive, and effective healthy experiences that will appeal to diverse communities of all ages. Brittney received a Bachelor of Science degree in Consumer Science / Education/Marketing from the University of Memphis and a Master of Public Health Degree from Saint Louis University.
Maria I. Florez, Research Consultant, Tufts CSDD, Founder, Brenner Insights, LLC
Maria Florez has been a researcher and consultant on the many facets of biopharmaceutical development for more than a decade. She is a researcher with the Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts University School of Medicine, and the founder of Brenner Insights—a consulting practice working with medicinal development stakeholders including foundations and NGOs, academic medical centers, research sites, and the biopharmaceutical industry. She has held strategy positions at Cleveland Clinic Innovations and New York-Presbyterian Hospital of Columbia and Cornell, as well as board and leadership positions at several health startups. At Tufts CSDD, she currently studies the impact of digital transformation in clinical research, organizational strategies and practices driving improvement in drug development operations, diversity and inclusion in clinical research, and the economics of drug development. She holds a B.S. with honors in quantitative economics from Stony Brook University, and an M.A. from The Fletcher School of Law and Diplomacy at Tufts University.
Shanell McGoy, PhD, MPH, Gilead Sciences, Director, Corporate and Social Responsibility
Dr. Shanell McGoy leads Gilead Science’s COMPASS Initiative, a 10-year, $100 million effort to address the HIV/AIDS epidemic in the Southern United States by supporting local communities and supporting evidence-based solutions to meet the needs of people living with and impacted by HIV/AIDS. She has a public health background and nearly 20 years of experience working in community-based organizations, academic settings and local, state, and federal government agencies. Prior to joining Gilead, she was the Director of HIV/STD for the Tennessee Department of Health. Dr. McGoy earned a Bachelor’s Degree from Spelman College; a Master of Public Health Degree from the University of Illinois at Chicago School of Public Health; and a Doctorate from Southern Illinois University – Carbondale. She completed her post-doctoral studies at Morehouse School of Medicine, she focused on health policy, equity, social determinants of health and behavioral health.